CNK1 is a Novel Akt Interaction Partner That Promotes Cell Proliferation Through the Akt-FoxO Signalling Axis

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2010 Apr 13

PMID 20383191

Citations 15

Authors

R D Fritz

Z Varga

G Radziwill

Affiliations

Soon will be listed here.

Abstract

The scaffold proteins connector enhancer of KSR (CNK) participate in Raf-, Rho- and NF-kappaB-dependent signalling and promote cell differentiation and invasion. In this study, we demonstrate that CNK1 downregulation inhibits, whereas CNK1 overexpression stimulates the proliferation of breast cancer cells and human embryonic kidney cells, respectively. This stimulatory effect depends on a functional phosphatidylinositol-3 kinase (PI3K) pathway because treatment of cells with the PI3K inhibitor, LY294002, abrogates CNK1-induced proliferation. CNK1 interacts with the PI3K effector Akt and knockdown of CNK1 decreases Akt activity in breast cancer cells. CNK1 controls Akt-dependent phosphorylation and transcriptional activity of FoxO, which is a negative regulator of proliferation. Consistent with this, CNK1-induced cell proliferation is blocked by FoxO overexpression. Moreover, CNK1 regulates anchorage-independent proliferation and focus formation of breast cancer cells. CNK1 is predominantly localized at the plasma membrane of breast cancer cells, whereas in non-transformed mammary epithelial cells, CNK1 is cytoplasmatic. Accordingly, CNK1 is found preferentially at the plasma membrane in carcinoma in situ and invasive breast cancer tumours compared with normal breast tissue sections. Analysis of multiple breast cancer samples reveals that CNK1-negative tumours show less Akt activity. Thus, CNK1 promotes oncogenic signalling through Akt in breast cancer cell lines and tumours.

Citing Articles

Regulation of Phosphoinositide Signaling by Scaffolds at Cytoplasmic Membranes.

Wen T, Thapa N, Cryns V, Anderson R Biomolecules. 2023; 13(9).

PMID: 37759697 PMC: 10526805. DOI: 10.3390/biom13091297.

Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling.

Li D, Miermont A, Sable R, Quadri H, Mathews Griner L, Martin S Mol Cancer Res. 2023; 21(4):316-331.

PMID: 36790955 PMC: 10068447. DOI: 10.1158/1541-7786.MCR-21-1036.

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer.

Zhang Y, Lin Y, Lv D, Wu X, Li W, Wang X PeerJ. 2022; 10:e12843.

PMID: 35127296 PMC: 8796709. DOI: 10.7717/peerj.12843.

CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.

Nishiyama K, Maekawa M, Nakagita T, Nakayama J, Kiyoi T, Chosei M Life Sci Alliance. 2021; 4(9).

PMID: 34187934 PMC: 8321701. DOI: 10.26508/lsa.202101095.

Disease-associated synaptic scaffold protein CNK2 modulates PSD size and influences localisation of the regulatory kinase TNIK.

Zieger H, Kunde S, Rademacher N, Schmerl B, Shoichet S Sci Rep. 2020; 10(1):5709.

PMID: 32235845 PMC: 7109135. DOI: 10.1038/s41598-020-62207-4.

References

Fritz R, Radziwill G . CNK1 promotes invasion of cancer cells through NF-kappaB-dependent signaling. Mol Cancer Res. 2010; 8(3):395-406. DOI: 10.1158/1541-7786.MCR-09-0296. View

Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung S . SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 2006; 127(1):125-37. DOI: 10.1016/j.cell.2006.08.033. View

Claperon A, Therrien M . KSR and CNK: two scaffolds regulating RAS-mediated RAF activation. Oncogene. 2007; 26(22):3143-58. DOI: 10.1038/sj.onc.1210408. View

Laberge G, Douziech M, Therrien M . Src42 binding activity regulates Drosophila RAF by a novel CNK-dependent derepression mechanism. EMBO J. 2005; 24(3):487-98. PMC: 548663. DOI: 10.1038/sj.emboj.7600558. View

Jaffe A, Hall A, Schmidt A . Association of CNK1 with Rho guanine nucleotide exchange factors controls signaling specificity downstream of Rho. Curr Biol. 2005; 15(5):405-12. DOI: 10.1016/j.cub.2004.12.082. View

Manning B, Cantley L . AKT/PKB signaling: navigating downstream. Cell. 2007; 129(7):1261-74. PMC: 2756685. DOI: 10.1016/j.cell.2007.06.009. View

Alessi D, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P . Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996; 15(23):6541-51. PMC: 452479. View

Rabizadeh S, Xavier R, Ishiguro K, Bernabeortiz J, Lopez-Ilasaca M, Khokhlatchev A . The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. J Biol Chem. 2004; 279(28):29247-54. DOI: 10.1074/jbc.M401699200. View

Sarbassov D, Guertin D, Ali S, Sabatini D . Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005; 307(5712):1098-101. DOI: 10.1126/science.1106148. View

10.

Manning B, Tee A, Logsdon M, Blenis J, Cantley L . Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell. 2002; 10(1):151-62. DOI: 10.1016/s1097-2765(02)00568-3. View

11.

Jaffe A, Aspenstrom P, Hall A . Human CNK1 acts as a scaffold protein, linking Rho and Ras signal transduction pathways. Mol Cell Biol. 2004; 24(4):1736-46. PMC: 344169. DOI: 10.1128/MCB.24.4.1736-1746.2004. View

12.

Kasper G, Reule M, Tschirschmann M, Dankert N, Stout-Weider K, Lauster R . Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway. BMC Cancer. 2007; 7:12. PMC: 1783860. DOI: 10.1186/1471-2407-7-12. View

13.

Lanigan T, Liu A, Huang Y, Mei L, Margolis B, Guan K . Human homologue of Drosophila CNK interacts with Ras effector proteins Raf and Rlf. FASEB J. 2003; 17(14):2048-60. DOI: 10.1096/fj.02-1096com. View

14.

Calnan D, Brunet A . The FoxO code. Oncogene. 2008; 27(16):2276-88. DOI: 10.1038/onc.2008.21. View

15.

Vivanco I, Sawyers C . The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002; 2(7):489-501. DOI: 10.1038/nrc839. View

16.

Fritz R, Radziwill G . The scaffold protein CNK1 interacts with the angiotensin II type 2 receptor. Biochem Biophys Res Commun. 2005; 338(4):1906-12. DOI: 10.1016/j.bbrc.2005.10.168. View

17.

Ziogas A, Moelling K, Radziwill G . CNK1 is a scaffold protein that regulates Src-mediated Raf-1 activation. J Biol Chem. 2005; 280(25):24205-11. DOI: 10.1074/jbc.M413327200. View

18.

Bellacosa A, Chan T, Ahmed N, Datta K, Malstrom S, Stokoe D . Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene. 1998; 17(3):313-25. DOI: 10.1038/sj.onc.1201947. View

19.

Fritzius T, Moelling K . Akt- and Foxo1-interacting WD-repeat-FYVE protein promotes adipogenesis. EMBO J. 2008; 27(9):1399-410. PMC: 2374844. DOI: 10.1038/emboj.2008.67. View

20.

Bumeister R, Rosse C, Anselmo A, Camonis J, White M . CNK2 couples NGF signal propagation to multiple regulatory cascades driving cell differentiation. Curr Biol. 2004; 14(5):439-45. DOI: 10.1016/j.cub.2004.02.037. View